Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bardou

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Clinical and Translational Science|April 29, 2026
Reply to: "Promising Drugs Require Proper Testing": Let's Not Confuse Pharmacodynamics With Clinical EfficacyInès Ben Ghezala, Marc Bardou
Clinical and Translational Science|June 2, 2026
Reply to "Preclinical and Clinical Evidence on Chloroquine or Hydroxychloroquine in COVID-19": Achieving Statistical Significance Does Not Mean That Clinical Relevance Can Be Disregarded, and This Must Be Considered When Interpreting ResultsInès Ben Ghezala, Marc Bardou
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Treatment of pancreatic cancer: A narrative review of cost-effectiveness studiesMarc Bardou, Isabelle Le Ray
Gut|July 28, 2010
Effect of statin therapy on colorectal cancerMarc Bardou, Alan Barkun, Myriam Martel
Drugs|March 28, 2009
Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disordersMarc Bardou, Janet Martin, Alan Barkun
Expert Opinion on Drug Metabolism & Toxicology|July 5, 2022
An update on drug-drug interactions associated with proton pump inhibitorsInès Ben Ghezala, Maxime Luu, Marc Bardou
Gut|March 14, 2013
Obesity and colorectal cancerMarc Bardou, Alan N Barkun, Myriam Martel
Annals of Internal Medicine|November 19, 2003
Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleedingAlan Barkun, Marc Bardou, John K Marshall, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 15, 2014
Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux diseaseFrançoise Goirand, Isabelle Le Ray, Marc Bardou
Alimentary Pharmacology & Therapeutics|December 17, 2020
Editorial: "Stardust gastric mucosa" - A novel and consistent marker of vonoprazan safety during follow-up?Maxime Luu, Ines Ben Ghezala, Marc Bardou
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Clinical and Translational Science|April 29, 2026
Reply to: "Promising Drugs Require Proper Testing": Let's Not Confuse Pharmacodynamics With Clinical EfficacyInès Ben Ghezala, Marc Bardou
Clinical and Translational Science|June 2, 2026
Reply to "Preclinical and Clinical Evidence on Chloroquine or Hydroxychloroquine in COVID-19": Achieving Statistical Significance Does Not Mean That Clinical Relevance Can Be Disregarded, and This Must Be Considered When Interpreting ResultsInès Ben Ghezala, Marc Bardou
Best Practice & Research. Clinical Gastroenterology|November 5, 2013
Treatment of pancreatic cancer: A narrative review of cost-effectiveness studiesMarc Bardou, Isabelle Le Ray
Gut|July 28, 2010
Effect of statin therapy on colorectal cancerMarc Bardou, Alan Barkun, Myriam Martel
Drugs|March 28, 2009
Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disordersMarc Bardou, Janet Martin, Alan Barkun
Expert Opinion on Drug Metabolism & Toxicology|July 5, 2022
An update on drug-drug interactions associated with proton pump inhibitorsInès Ben Ghezala, Maxime Luu, Marc Bardou
Gut|March 14, 2013
Obesity and colorectal cancerMarc Bardou, Alan N Barkun, Myriam Martel
Annals of Internal Medicine|November 19, 2003
Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleedingAlan Barkun, Marc Bardou, John K Marshall, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 15, 2014
Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux diseaseFrançoise Goirand, Isabelle Le Ray, Marc Bardou
Alimentary Pharmacology & Therapeutics|December 17, 2020
Editorial: "Stardust gastric mucosa" - A novel and consistent marker of vonoprazan safety during follow-up?Maxime Luu, Ines Ben Ghezala, Marc Bardou
Pageof 15